GLP-1 agonist medications work by mimicking this hormone. In medication terms, an agonist is a manufactured substance that attaches to a cell receptor and causes the same action as the naturally occurring substance.
To gain a better understanding, the authors modified the GLP-1 receptors of mice with gene-editing techniques, making them more humanlike. The team administered orforglipron or another small-molecule drug, danuglipron, and identified brain regions where they induced activity.
GLP-1 receptor agonists were initially developed to treat type 2 diabetes and have had a transformative effect on its therapy, and are highly effective for glycaemic control, with the added benefit of bodyweight reduction and a low risk of causing hypoglycaemia. GLP-1 receptor agonists reduce risks for major adverse cardiovascular events (eg, non-fatal myocardial infarction, stroke, and ...
Glucagon-like peptide-1 (GLP-1) is an incretin hormone normally secreted by neuroendocrine L cells of the gastrointestinal tract after food ingestion that augments glucose-dependent insulin secretion by pancreatic islet cells. Additionally, GLP-1 reduces glucagon secretion by islet cells, slows gastric emptying, and reduces appetite through effects on the hypothalamus.1 GLP-1 receptor ...
Objective: The GLP-1 receptor antagonist exendin(9-39)NH2 (ex9-39) was used to further explore the role of GLP-1 as an endogenous satiation signal. Design: Two double-blind, 4-way crossover studies were performed, each of which included 10 healthy men.
